Effective August 1, 2024, this database was discontinued. All content will remain searchable and be preserved online for historical purposes only until 2029.
Cutaneous T-cell Lymphoma
What's New
Last Posted: Jun 28, 2023
- Involvement of cutavirus in a subset of patients with cutaneous T-cell lymphoma with an unfavorable outcome.
Yumiko Hashida, et al. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2023 0 105523 - Genomic analysis reveals recurrent deletion of JAK-STAT signaling inhibitors HNRNPK and SOCS1 in mycosis fungoides.
Bastidas Torres Armando N, et al. Genes, chromosomes & cancer 2018 0 (12) 653-664 - Differential SATB1 Expression Reveals Heterogeneity of Cutaneous T-Cell Lymphoma.
Gao Yumei, et al. The Journal of investigative dermatology 2020 0 (3) 607-618.e6 - A computational in silico approach to predict high-risk coding and non-coding SNPs of human PLCG1 gene.
Khan Safayat Mahmud, et al. PloS one 2021 0 (11) e0260054 - mRNA-Based Anti-TCR CDR3 Tumour Vaccine for T-Cell Lymphoma.
Tusup Marina, et al. Pharmaceutics 2021 0 (7) - Genetic polymorphisms in immunity related genes and the vitamin D receptor gene and risk of cutaneous T-cell lymphoma in Greek population.
Velissari A, et al. Journal of the European Academy of Dermatology and Venereology : JEADV 2021 0 (11) e805-e807 - Deregulation of JAK2 signaling underlies primary cutaneous CD8 aggressive epidermotropic cytotoxic T-cell lymphoma.
Bastidas Torres Armando N, et al. Haematologica 2021 0 (3) 702-714 - Spectrum of mutational signatures in T-cell lymphoma reveals a key role for UV radiation in cutaneous T-cell lymphoma.
Jones Christine L, et al. Scientific reports 2021 0 (1) 3962 - Single-cell RNA-sequencing reveals predictive features of response to pembrolizumab in Sézary syndrome.
Su Tianying, et al. Oncoimmunology 2022 0 (1) 2115197 - Identification of OAF and PVRL1 as candidate genes for an ocular anomaly characterized by Peters anomaly type 2 and ectopia lentis.
David Dezs?, et al. Experimental eye research 2018 0 161-170 - Association of the POT1 Germline Missense Variant p.I78T With Familial Melanoma.
Wong Kim, et al. JAMA dermatology 2018 0 (5) 604-609 - Interleukin-17 Genes Polymorphisms are Significantly Associated with Cutaneous T-cell Lymphoma Susceptibility.
Ko?kowski Karol, et al. Acta dermato-venereologica 2022 9 adv00777 - Genetically driven CD39 expression affects Sezary cell viability, IL-2 production and detects two patient subsets with distinct prognosis.
Picozza Mario, et al. The Journal of investigative dermatology 2022 5 - Deep Learning for Diagnostic Binary Classification of Multiple-Lesion Skin Diseases.
Thomsen Kenneth et al. Frontiers in medicine 2020 7574329 - Association of APOA5 and APOC3 Genetic Polymorphisms With Severity of Hypertriglyceridemia in Patients With Cutaneous T-Cell Lymphoma Treated With Bexarotene.
Cabello Irene, et al. JAMA dermatology 2018 12 (12) 1424-1431 - Candidate driver genes involved in genome maintenance and DNA repair in Sézary syndrome.
Woollard Wesley J, et al. Blood 2016 0 (26) 3387-97 - Structural variation of centromeric endogenous retroviruses in human populations and their impact on cutaneous T-cell lymphoma, Sézary syndrome, and HIV infection.
Kaplan Mark H, et al. BMC medical genomics 2019 5 (1) 58 - Local Coverage Determination (LCD): Flow Cytometry (L33661)
The U.S. Centers for Medicare & Medicaid Services - The role of polymorphism of interleukin-2, -10, -13 and TNF-? genes in cutaneous T-cell lymphoma pathogenesis.
Nedoszytko Boguslaw, et al. Postepy dermatologii i alergologii 2016 12 (6) 429-434 - Mycosis fungoides: association of KIR ligands and HLA-DQB1*05 with bad prognosis of the disease.
Brazzelli V, et al. Journal of the European Academy of Dermatology and Venereology : JEADV 2015 3 - Immunogenetic factors in mycosis fungoides: can the HLA system influence the susceptibility and prognosis of the disease? Long-term follow-up study of 46 patients.
Brazzelli V, et al. Journal of the European Academy of Dermatology and Venereology : JEADV 2014 12 (12) 1732-7 - Cutaneous T-cell lymphoma
From NCATS Genetic and Rare Diseases Information Center - Matrix metalloproteinase-2 promoter genotype as a marker of cutaneous T-cell lymphoma early stage.
Vasku Anna, et al. Journal of biomedicine & biotechnology 2010 0 805907 - Characterization of UGTs active against SAHA and association between SAHA glucuronidation activity phenotype with UGT genotype.
Balliet RM, et al. Cancer research 2009 4 (7) 7 - Population pharmacokinetics of romidepsin in patients with cutaneous T-cell lymphoma and relapsed peripheral T-cell lymphoma.
Woo Sukyung, et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2009 2 (4) 1496-503 - Pharmacogenetic contribution of leptin gene polymorphism in cutaneous T-cell lymphoma.
Vasku Vladimir, et al. International journal of clinical and experimental pathology 2009 0 (2) 163-8 - Association of variants in angiotensin-converting enzyme and endothelin-1 genes with phototherapy in cutaneous T-cell lymphoma.
Vaskù V, et al. Acta dermatovenerologica Alpina, Pannonica, et Adriatica 2004 12 (4) 111-6, 118 - Heterozygote AG variant of -596 A/G IL-6 gene polymorphism is a marker for cutaneous T-cell lymphoma (CTCL).
Vasku Julie Anna, et al. Clinical immunology (Orlando, Fla.) 2004 12 (3) 256-60
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
Browse full list of rare diseases
A-Z
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: